Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 03 04:00PM ET
24.80
Dollar change
+0.10
Percentage change
0.39
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Shs Outstand Perf Week4.28%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings46 Perf Month-2.76%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM10.86M Perf Quarter-3.51%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range23.67 - 26.74 Perf YTD-2.72%
Dividend TTM- ESG Type Tags- Flows% 3M0.00% 52W High-7.26% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD5591.57% 52W Low4.77% ATR (14)0.25
Expense0.75% Structure Type Region Flows% 1Y RSI (14)52.30 Volatility0.50% 0.42%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.78 Prev Close24.70
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.40K Price24.80
SMA201.45% SMA50-2.08% SMA200-2.27% Trades Volume703 Change0.39%
Tema Neuroscience And Mental Health ETF seeks to provide long-term growth of capital. Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.